{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "72-year-old former smoker with cT2aN3M1c stage IVB lung squamous cell carcinoma presented with dyspnea and cough.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung Cancer",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C448715",
              "label": "stage IVB lung squamous cell carcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "former smoker"
            }
          ],
          "HPI": [
            {
              "summary": "patient presented with dyspnea and cough",
              "duration": null,
              "onset": null,
              "progression": "unknown",
              "associated_symptoms": [
                "R06.02",
                "R05"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient reached complete response to pembrolizumab treatment but suffered from grade 2 chemotherapy-induced peripheral neuropathy (CIP).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0030705",
              "indication": "C0009450"
            }
          ],
          "diagnoses": [
            {
              "code": "C0085648",
              "label": "Peripheral neuropathy",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Pembrolizumab treatment was discontinued due to pembrolizumab\u2010related pneumonitis. Patient was receiving prednisolone (PSL, 50\u2009mg/day).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0032463",
              "dosage": "50 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "indication": "C0032463",
              "start_date": null,
              "end_date": null
            }
          ],
          "allergies": [
            {
              "substance": "pembrolizumab",
              "reaction": "pneumonitis",
              "severity": null,
              "date_recorded": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "CIP was partially relieved by steroid treatment. Steroid dose was reduced by 5-10 mg every 2 weeks and finally reduced to 5 mg/day. On admission, the patient was hypoxemic (SpO2 88% at room air) but had no fever. Blood tests revealed high white blood cell (WBC) (12,900/\u03bcL) and C-reactive protein (CRP) (15.1 mg/dL) levels.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0037974",
              "dosage": "5-10 mg",
              "frequency": "every 2 weeks",
              "modality": "oral",
              "indication": "C0007097"
            },
            {
              "drug": "C0037974",
              "dosage": "5 mg/day",
              "modality": "oral",
              "indication": "C0007097"
            }
          ],
          "vitals": [
            {
              "type": "C0040242",
              "value": "88",
              "unit": "%",
              "timestamp": null
            }
          ],
          "labs": [
            {
              "test": "C0043259",
              "value": "12900",
              "unit": "/\u03bcL",
              "flag": "abnormal"
            },
            {
              "test": "C0009451",
              "value": "15.1",
              "unit": "mg/dL",
              "flag": "abnormal"
            }
          ],
          "diagnoses": [
            {
              "code": "C0007097",
              "label": "CIP",
              "status": "active"
            },
            {
              "code": "C0020515",
              "label": "Hypoxemia",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Serum levels of lactate dehydrogenase (LD) and Krebs von den Lungen (KL)-6 were normal. Serological tests for autoantibodies against specific antigens were all negative. Chest computed tomography (CT) revealed new bilateral diffuse infiltrative and ground-glass opacification in both lung fields, with partial attenuation of a previous infiltrative shadow in the right upper lobe. Bronchoalveolar lavage fluid was negative for microbes.",
        "clinical_data": {
          "labs": [
            {
              "test": "Lactate Dehydrogenase Measurement",
              "value": "normal",
              "unit": null,
              "flag": "normal"
            }
          ],
          "imaging": [
            {
              "type": "Computed tomography of chest",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Bilateral diffuse infiltrative and ground-glass opacification in both lung fields, with partial attenuation of a previous infiltrative shadow in the right upper lobe."
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Histological examination of a transbronchial lung biopsy specimen revealed organization and lymphocyte infiltration in the alveolar spaces. No malignant findings were observed. Patient was diagnosed with grade 3 ICI-related steroid-refractory organizing pneumonia caused by pembrolizumab. Chest CT 3 months before admission showed consolidation and ground\u2010glass opacities with an air",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C536372",
              "label": "Organizing Pneumonia",
              "status": "active",
              "onset_date": null
            }
          ],
          "medications": [
            {
              "drug": "C4049447",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "ICI-related pneumonitis"
            }
          ],
          "imaging": [
            {
              "type": "C4026743",
              "body_part": "C716480",
              "modality": "CT",
              "finding": "Consolidation",
              "impression": "Ground-glass opacity",
              "date": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient with lung squamous cell carcinoma responded to pembrolizumab but developed grade 2 chemotherapy-induced peripheral neuropathy (CIP)."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Pembrolizumab was discontinued due to pembrolizumab\u2010related pneumonitis. Patient was started on prednisolone (PSL, 50\u2009mg/day).",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0030705",
            "C0032463"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "CIP was partially relieved by steroid treatment. Steroid dose was reduced to 5 mg/day. Patient was hypoxemic (SpO2 88% at room air) with high WBC (12,900/\u03bcL) and CRP (15.1 mg/dL) levels.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0037974"
          ],
          "change_type": "deescalation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "LD and KL-6 were normal. Autoantibody tests were negative. Chest CT showed new bilateral diffuse infiltrative and ground-glass opacification, with partial attenuation of a previous shadow.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0022924"
          ],
          "change_type": "resolution",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Lung biopsy revealed organization and lymphocyte infiltration. No malignant findings. Patient diagnosed with grade 3 ICI-related steroid-refractory organizing pneumonia caused by pembrolizumab.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C536372"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    }
  ]
}